Måndag 1 September | 06:42:20 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-06-04 07:00 Bokslutskommuniké 2026
2026-03-02 07:00 Kvartalsrapport 2026-Q3
2025-12-01 07:00 Kvartalsrapport 2026-Q2
2025-09-25 N/A X-dag ordinarie utdelning INTEG B 0.00 SEK
2025-09-24 N/A Årsstämma
2025-09-01 07:00 Kvartalsrapport 2026-Q1
2025-06-03 - Bokslutskommuniké 2025
2025-03-03 - Kvartalsrapport 2025-Q3
2025-01-20 - Extra Bolagsstämma 2025
2024-12-04 - Kvartalsrapport 2025-Q2
2024-09-26 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2024-09-25 - Årsstämma
2024-08-29 - Kvartalsrapport 2025-Q1
2024-05-30 - Bokslutskommuniké 2024
2024-02-29 - Kvartalsrapport 2024-Q3
2023-12-04 - Kvartalsrapport 2024-Q2
2023-10-04 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2023-09-27 - Årsstämma
2023-08-31 - Kvartalsrapport 2024-Q1
2023-06-08 - Bokslutskommuniké 2023
2023-03-01 - Kvartalsrapport 2023-Q3
2022-12-01 - Kvartalsrapport 2023-Q2
2022-10-03 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2022-09-28 - Årsstämma
2022-08-31 - Kvartalsrapport 2023-Q1
2022-06-10 - Bokslutskommuniké 2022
2022-03-02 - Kvartalsrapport 2022-Q3
2021-12-02 - Kvartalsrapport 2022-Q2
2021-09-09 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2021-09-02 - Kvartalsrapport 2022-Q1
2021-05-31 - Bokslutskommuniké 2021
2021-03-03 - Kvartalsrapport 2021-Q3
2020-12-02 - Kvartalsrapport 2021-Q2
2020-09-30 - Årsstämma
2020-09-09 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2020-08-24 - Kvartalsrapport 2021-Q1
2020-06-08 - Bokslutskommuniké 2020
2020-04-20 - Extra Bolagsstämma 2020
2020-03-02 - Kvartalsrapport 2020-Q3
2019-12-02 - Kvartalsrapport 2020-Q2
2019-09-30 - Årsstämma
2019-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2019-09-02 - Kvartalsrapport 2020-Q1
2019-06-10 - Bokslutskommuniké 2019
2019-03-04 - Kvartalsrapport 2019-Q3
2018-12-17 - Kvartalsrapport 2019-Q2
2018-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2018-09-24 - Årsstämma
2018-09-24 - Kvartalsrapport 2019-Q1
2018-06-25 - Bokslutskommuniké 2018
2018-03-26 - Kvartalsrapport 2018-Q3
2017-12-18 - Kvartalsrapport 2018-Q2
2017-09-25 - Årsstämma
2017-09-25 - Kvartalsrapport 2018-Q1
2017-06-30 - Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Integrum är verksamt inom medicinteknik. Bolaget utvecklar system för skelettförankrade proteser baserat på det framtagna OPRA-implantatsystemet, som senare vidaresäljs till sjukhus världen över. Implantatet sätts på patientens ben med hjälp utav titanskruvar och antas förbättra livet för en stor del patienter med amputation. Bolaget grundades 1998 och har sitt huvudkontor i Mölndal.
2025-08-13 15:25:44

Mölndal, Sweden, August 13, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), the provider of the OPRA™ Implant System, has announced that it has secured the exclusive title of Legacy Sponsor - the highest level of sponsorship - for the Global Collaborative Congress on Osseointegration (GCCO) annual meeting, held in Charlotte, North Carolina, USA.

This multi-year sponsorship grants Integrum exclusive top-tier recognition for the next three years and underscores the company's long-standing commitment to clinical education, surgical innovation, and international collaboration in the field of osseointegration, known as bone-anchored prosthetics. As a Legacy Sponsor, Integrum will continue to support the global limb loss community by fostering research, advancing outcomes, and engaging cross-disciplinary education.

"We're proud to serve as top sponsor of the GCCO conference. This partnership reflects our shared commitment to facilitating innovation and fostering global collaboration to expand limb loss care. We believe in the power of shared knowledge and scientific evidence to drive long-term impact," said Jeffrey Zanni, President of Integrum Inc.

The GCCO conference brings together leaders in surgical innovation, rehabilitation, prosthetics and clinical research to further the progress being made in the field of bone-anchored prosthetics.

"Integrum's support has been instrumental in driving forward the mission of GCCO-to unite experts across borders to advance limb loss care. Their commitment to innovation and education elevates the quality of our conversations and enables us to continue improving outcomes for amputees worldwide," said Dr. Joseph Hsu, conference chair and orthopedic trauma surgeon.

Integrum's top sponsorship reflects its mission to provide freedom of mobility for every person by driving improved outcomes and greater access to advanced prosthetic solutions. The company remains committed to supporting GCCO's mission and upholding shared objectives within the osseointegration space.

For more information about Integrum or the OPRA™ Implant System, visit https://integrum.se/.​

For registration and more information about the GCCO conference visit https://whova.com/portal/registration/1alq-wqaCdERx3smTUms/.